Sihuan Pharmaceutical Holdings Group Ltd. (HKG:0460)

HKG:0460 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,257	3,522	3,779	3,829	5,682	4,604
Trading Asset Securities	341.71	110.58	589.02	962.99	109.3	332.68
Cash & Short-Term Investments	3,599	3,633	4,368	4,792	5,792	4,937
Cash Growth	-26.02%	-16.82%	-8.85%	-17.26%	17.32%	-6.24%
Accounts Receivable	736.29	593.93	397.82	522.25	779.07	389.82
Other Receivables	327.02	303.21	262.32	342.67	100.36	317.66
Receivables	1,373	1,305	1,045	977.61	1,094	820.92
Inventory	472.25	417	557.32	606.7	715.3	495.89
Other Current Assets	374.24	362.32	233.61	174.23	140.09	150.62
Total Current Assets	5,818	5,718	6,204	6,550	7,741	6,404
Property, Plant & Equipment	2,576	2,635	2,842	2,998	4,093	3,841
Long-Term Investments	843.48	818.04	1,004	907.34	972.53	1,267
Goodwill	1.85	1.85	1.85	1.85	14.17	12.31
Other Intangible Assets	899.05	598.76	655.52	594.1	445.8	310.92
Long-Term Deferred Tax Assets	30.76	32.13	31.77	96.77	303.46	269.45
Long-Term Deferred Charges	-	242.97	120.44	32.36	164.3	194.7
Other Long-Term Assets	452.48	362.32	359.63	393.46	393.84	400.82
Total Assets	10,622	10,532	11,535	12,141	14,496	13,044
Accounts Payable	284.49	241.93	215.15	205.78	118.91	106.2
Accrued Expenses	409.34	490.06	504.92	700.08	1,077	986.09
Short-Term Debt	15.75	31.24	5.46	25.8	30	283.29
Current Portion of Long-Term Debt	181.56	137.04	269.68	315.17	170	108.64
Current Portion of Leases	9.8	14.06	24.5	21.3	5.19	1.44
Current Income Taxes Payable	68.57	63.97	44.21	67.86	111.25	22.45
Current Unearned Revenue	106.54	110.02	143.05	175.92	214.11	197.11
Other Current Liabilities	2,251	2,222	2,900	1,021	775.11	737.87
Total Current Liabilities	3,327	3,310	4,107	2,533	2,502	2,443
Long-Term Debt	768.76	746.29	905.03	848.67	844.75	359.17
Long-Term Leases	51.22	45.38	51.98	79.94	31.46	2.51
Long-Term Unearned Revenue	298.08	313.31	163.28	135.81	82.34	64.74
Long-Term Deferred Tax Liabilities	4.38	5.26	70.32	99.04	222.39	225.69
Other Long-Term Liabilities	1,231	1,162	1,101	2,804	1,663	-
Total Liabilities	5,681	5,582	6,398	6,501	5,346	3,095
Common Stock	77.06	77.06	77.06	77.06	77.06	78.19
Additional Paid-In Capital	3,882	3,882	3,882	3,882	3,882	4,085
Retained Earnings	599.21	941.2	1,336	1,691	4,922	4,628
Treasury Stock	-132.45	-54.11	-33.81	-	-	-
Comprehensive Income & Other	-41.21	-474.2	-829.01	-913.86	-597.15	398.83
Total Common Equity	4,385	4,372	4,432	4,737	8,284	9,190
Minority Interest	556.13	577.05	704.89	902.83	865.92	758.38
Shareholders' Equity	4,941	4,949	5,137	5,640	9,150	9,949
Total Liabilities & Equity	10,622	10,532	11,535	12,141	14,496	13,044
Total Debt	1,027	974.01	1,257	1,291	1,081	755.05
Net Cash (Debt)	2,572	2,659	3,111	3,501	4,710	4,182
Net Cash Growth	-31.23%	-14.53%	-11.14%	-25.67%	12.64%	-20.30%
Net Cash Per Share	0.28	0.29	0.33	0.38	0.50	0.44
Filing Date Shares Outstanding	9,128	9,244	9,282	9,330	9,330	9,466
Total Common Shares Outstanding	9,128	9,244	9,282	9,330	9,330	9,466
Working Capital	2,491	2,407	2,097	4,017	5,240	3,961
Book Value Per Share	0.48	0.47	0.48	0.51	0.89	0.97
Tangible Book Value	3,484	3,772	3,775	4,141	7,824	8,867
Tangible Book Value Per Share	0.38	0.41	0.41	0.44	0.84	0.94
Buildings	-	3,526	3,539	3,596	2,956	2,763
Machinery	-	1,635	1,572	1,505	1,288	1,147
Construction In Progress	-	205.93	295.53	346.87	819.92	680.28

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.